Blog
What We Do
Galectin Proteins
Develop Proprietary Galectin Inhibitors
Discovery Programs
Intellectual Property
Our Pipeline
Pipeline Overview
Development Programs
About
About Us
Leadership
Board of Directors
Special Consultants
Careers
Investor Relations
Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
FAQs
Email Alert Subscription
Learn More
About Belapectin
About Galectin-3
About the NAVIGATE Study
Resources
Video Library
Publications
News
Contact Us
Open Menu
What We Do
Galectin Proteins
Develop Proprietary Galectin Inhibitors
Discovery Programs
Intellectual Property
Our Pipeline
Pipeline Overview
Development Programs
About
About Us
Leadership
Board of Directors
Special Consultants
Careers
Investor Relations
Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
FAQs
Email Alert Subscription
Learn More
About Belapectin
About Galectin-3
About the NAVIGATE Study
Resources
Video Library
Publications
News
Contact Us
About Belapectin
About Galectin-3
About the NAVIGATE Study
Resources
Video Library
Publications
News
News
Press Releases
03/12/24
Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development
11/13/23
UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
11/13/23
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
View All
In The News
04/27/21
BioSpace: Galectin Therapeutics Launches NASH Cirrhosis Info Site for Physicians and Patients
04/21/21
Drug Discovery & Development: Ben Carson joins Galectin Therapeutics as ‘special consultant’
04/19/21
Endpoints News: The doctor is in: Trump insider Ben Carson joins NASH player Galectin as a 'special consultant,' part-time spokesman
04/13/21
Healio: VIDEO: Website provides up-to-date data from NASH cirrhosis study
11/17/20
PharmaVOICE: 2021 Year in Preview: The Year to Come and the Year That Was
09/09/20
Healio: Q&A: Phase 2b trial shows belapectin may reduce incidence of new esophageal varices